Vis Plus
Vis Plus, licence 80093991: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Vis Plus Softgel, Vision Plus Softgel
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80093991
- Status
- Active licence
- Licence date
- 19 August 2019
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 25.0 % Docosahexaenoic acid | 200.0 mg | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 50.0 % Eicosapentaenoic acid | Not specified | Not calculated |
| Vitamine C Source : Acide ascorbique | 50.0 mg | 50,000 µg |
| Vitamine C Source : Ascorbate de sodium | 100.0 mg | 100,000 µg |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 30.0 UI | Not calculated |
| Zinc Source : Oxyde de zinc | 9.0 mg | 9,000 µg |
| Cuivre Source : Gluconate de cuivre (II) | 1.0 mg | 1,000 µg |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 6.0 mg | Not calculated |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Lutéine(USP) | 6.0 mg | Not calculated |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 0.6 mg | Not calculated |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Zeaxanthin | 0.6 mg | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 13.5 mg AT | Not calculated |
Non-medicinal ingredients
Gélatine, Lécithine, Rouge FD&C N° 40, Huile de fève de soja, Eau purifiée, Dioxyde de titane, Cire d'abeille, Bleu FD&C n° 1, Jaune FD&C No. 5, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of eye health. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80093991
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.